IG vs ID Bitter Administration

NCT03985865 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Intragastric quinine hydrochloride
DRUG: Intragastric denatonium benzoate
DRUG: Intragastric placebo
DRUG: Intraduodenal quinine hydrochloride
DRUG: Intraduodenal denatonium benzoate
DRUG: Intraduodenal placebo

Sponsor

Universitaire Ziekenhuizen KU Leuven